Cystic fibrosis (CF) is characterized by pancreatic insufficiency leading to malabsorption and various gastrointestinal issues, with severe cases often presenting in infancy. Respiratory complications, primarily from lung infections, are the leading cause of mortality in CF patients, while liver disease and infertility are also significant concerns. Advances in treatment have improved management of CF, including new therapies targeting CFTR protein function.
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0 ratings0% found this document useful (0 votes)
38 views1 page
Robbins Basic Pathology (1) - 1
Cystic fibrosis (CF) is characterized by pancreatic insufficiency leading to malabsorption and various gastrointestinal issues, with severe cases often presenting in infancy. Respiratory complications, primarily from lung infections, are the leading cause of mortality in CF patients, while liver disease and infertility are also significant concerns. Advances in treatment have improved management of CF, including new therapies targeting CFTR protein function.
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 1
Mendelian Disorders: Diseases Caused by Single-Gene Defects 253
is not required—the pancreas-sufficient phenotype.
Pancreatic insufficiency is associated with malabsorption of protein and fat and increased fecal loss. Manifestations of malabsorption (e.g., large, foul-smelling stools; abdomi- nal distention; poor weight gain) appear during the first year of life. The faulty fat absorption may induce defi- ciency states of the fat-soluble vitamins, resulting in mani- festations of avitaminosis A, D, or K. Hypoproteinemia may be severe enough to cause generalized edema. Persis- tent diarrhea may result in rectal prolapse in as many as 10% of children with CF. The pancreas-sufficient pheno- type usually is not associated with other gastrointestinal complications, and in general, these patients demonstrate excellent growth and development. In contrast to exocrine insufficiency, endocrine insufficiency (i.e., diabetes) is uncommon in CF and occurs late in the course of the disease especially with improved survival of patients with CF. Cardiorespiratory complications, such as chronic cough, persistent lung infections, obstructive pulmonary disease, and cor pulmonale, constitute the most common cause of death (accounting for approximately 80% of fatalities) in Fig. 7.6 Lungs of a patient who died of cystic fibrosis. Extensive mucous patients who receive follow-up care in most CF centers plugging and dilation of the tracheobronchial tree are apparent. The pul- in the United States. By 18 years of age, 80% of patients monary parenchyma is consolidated by a combination of both secretions with classic CF harbor P. aeruginosa, and 3.5% harbor B. and pneumonia; the greenish discoloration is the product of Pseudomo- cepacia. With the indiscriminate use of antibiotic prophy- nas infections. (Courtesy of Dr. Eduardo Yunis: Children’s Hospital of Pittsburgh, laxis, there has been an unfortunate resurgence of resis- Pittsburgh, Pennsylvania.) tant strains of Pseudomonas in many patients. Significant liver disease occurs late in the natural history of CF and is foreshadowed by pulmonary and pancreatic involve- bronchiectasis. Development of lung abscesses is common. Staph- ment; with increasing life expectancy, liver disease is ylococcus aureus, Haemophilus influenzae, and Pseudomonas aeru- now the third most common cause of death in patients ginosa are the three most common organisms responsible for with CF (after cardiopulmonary and transplant-related lung infections. Even more sinister is the increasing frequency of complications). More extensive DNA sequencing has infection with another pseudomonad, Burkholderia cepacia. This shown that the spectrum of diseases caused by germline opportunistic bacterium is particularly hardy, and infection with CFTR mutations (either biallelic or in heterozygous car- this organism has been associated with fulminant illness (“cepacia riers) is broader than the “classic” multisystem disease syndrome”). The liver involvement follows the same basic described earlier. For example, some patients suffering pattern. Bile canaliculi are plugged by mucinous material, accom- from recurrent bouts of abdominal pain and pancreatitis panied by ductular proliferation and portal inflammation. Hepatic since childhood who were previously classified as having steatosis (“fatty liver”) is a common finding in liver biopsies. “idiopathic” chronic pancreatitis are now known to harbor With time, cirrhosis develops, resulting in diffuse hepatic nodu- biallelic CFTR variants that are distinct from those seen in larity. Such severe hepatic involvement is encountered in less “classic” CF. Patients with isolated pancreatitis or bilateral than 10% of patients. Azoospermia and infertility are found absence of vas deferens (see earlier) resulting from CFTR in 95% of the affected males who survive to adulthood; bilateral mutations are included under the umbrella of “CFTR- absence of the vas deferens is a frequent finding in these opathies.” Similarly, whereas CF carriers were initially patients. In some males, this may be the only feature suggesting thought to be asymptomatic, studies suggest that they an underlying CFTR mutation. have an increased lifetime risk for chronic lung disease (especially bronchiectasis) and recurrent sinonasal polyps. In most cases, the diagnosis of CF is based on persistently elevated sweat electrolyte concentrations (often the mother Clinical Course makes the diagnosis because her infant “tastes salty”), In few childhood diseases are clinical manifestations as characteristic clinical findings (sinopulmonary disease protean as those of CF (Fig. 7.4). Approximately 5% to 10% and gastrointestinal manifestations), or a family history. of the cases come to clinical attention at birth or soon after Sequencing the CFTR gene is the gold standard for diagnosis because of an attack of meconium ileus. Exocrine pancre- of CF. atic insufficiency occurs in a majority (85% to 90%) of There have been major improvements in the manage- patients and is associated with “severe” CFTR mutations ment of acute and chronic complications of CF, including on both alleles (e.g., ΔF508/ΔF508). By contrast, 10% to 15% more potent anti-microbial therapies, pancreatic enzyme of patients, who have one “severe” and one “mild” CFTR replacement, and bilateral lung transplantation. Impor- mutation, or two “mild” CFTR mutations, retain sufficient tantly, two new forms of treatment aimed at increasing pancreatic exocrine function that enzyme supplementation CFTR protein function in certain CFTR variants have been